These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9036151)

  • 1. A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain.
    Horrevoets AJ; Pannekoek H; Nesheim ME
    J Biol Chem; 1997 Jan; 272(4):2183-91. PubMed ID: 9036151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
    J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis.
    Horrevoets AJ; Smilde A; de Vries C; Pannekoek H
    J Biol Chem; 1994 Apr; 269(17):12639-44. PubMed ID: 8175674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of recombinant human plasminogen(S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease.
    Horrevoets AJ; Pannekoek H; Nesheim ME
    J Biol Chem; 1997 Jan; 272(4):2176-82. PubMed ID: 8999920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
    de Vries C; Veerman H; Koornneef E; Pannekoek H
    J Biol Chem; 1990 Aug; 265(23):13547-52. PubMed ID: 2143185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ; Fredenburgh JC; Weitz JI
    J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator.
    Arza B; Hoylaerts MF; Félez J; Collen D; Lijnen HR
    Eur J Biochem; 2000 Nov; 267(21):6378-84. PubMed ID: 11029580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
    Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
    Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].
    Taran LD; Makogonenko EM
    Ukr Biokhim Zh (1978); 1989; 61(4):31-6. PubMed ID: 2511651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reexamination of the extent of the activation of Lys78 plasminogen by tissue plasminogen activator in the presence of polymerized fibrin.
    Urano T; Takada Y; Ihara H; Takada A
    Haemostasis; 1996; 26(4):220-7. PubMed ID: 8872134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
    Bakker AH; Rehberg EF; Marotti KR; Verheijen JH
    Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
    Suenson E; Bjerrum P; Holm A; Lind B; Meldal M; Selmer J; Petersen LC
    J Biol Chem; 1990 Dec; 265(36):22228-37. PubMed ID: 2148318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
    Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
    J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator.
    Kim PY; Tieu LD; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2012 Feb; 287(7):4652-61. PubMed ID: 22187433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
    van Zonneveld AJ; Veerman H; Pannekoek H
    J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.
    Verheijen JH; Caspers MP; Chang GT; de Munk GA; Pouwels PH; Enger-Valk BE
    EMBO J; 1986 Dec; 5(13):3525-30. PubMed ID: 3030730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
    Hancock MA; Boffa MB; Marcovina SM; Nesheim ME; Koschinsky ML
    J Biol Chem; 2003 Jun; 278(26):23260-9. PubMed ID: 12697748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R; Geiger M; de Vries C; Pannekoek H; Binder BR
    J Biol Chem; 1991 Feb; 266(4):2227-32. PubMed ID: 1824940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.